| Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer S Varambally, Q Cao, RS Mani, S Shankar, X Wang, B Ateeq, B Laxman, ... science 322 (5908), 1695-1699, 2008 | 1366 | 2008 |
| An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ... Cancer cell 17 (5), 443-454, 2010 | 1014 | 2010 |
| Repression of E-cadherin by the polycomb group protein EZH2 in cancer Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ... Oncogene 27 (58), 7274-7284, 2008 | 673 | 2008 |
| Induced chromosomal proximity and gene fusions in prostate cancer RS Mani, SA Tomlins, K Callahan, A Ghosh, MK Nyati, S Varambally, ... Science 326 (5957), 1230-1230, 2009 | 453 | 2009 |
| Coordinated regulation of polycomb group complexes through microRNAs in cancer Q Cao, RS Mani, B Ateeq, SM Dhanasekaran, IA Asangani, JR Prensner, ... Cancer cell 20 (2), 187-199, 2011 | 238 | 2011 |
| Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences RS Mani, AM Chinnaiyan Nature Reviews Genetics 11 (12), 819-829, 2010 | 197 | 2010 |
| TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer R Banerjee, N Russo, M Liu, V Basrur, E Bellile, N Palanisamy, ... Nature communications 5 (1), 4527, 2014 | 184 | 2014 |
| Contribution of connexin26 (GJB2) mutations and founder effect to non-syndromic hearing loss in India M RamShankar, S Girirajan, O Dagan, HMR Shankar, R Jalvi, ... Journal of Medical Genetics 40 (5), e68-e68, 2003 | 173 | 2003 |
| Prostate carcinogenesis: inflammatory storms JS de Bono, C Guo, B Gurel, AM De Marzo, KS Sfanos, RS Mani, J Gil, ... Nature Reviews Cancer 20 (8), 455-469, 2020 | 159 | 2020 |
| BRD4 promotes DNA repair and mediates the formation of TMPRSS2-ERG gene rearrangements in prostate cancer X Li, GH Baek, SG Ramanand, A Sharp, Y Gao, W Yuan, J Welti, ... Cell reports 22 (3), 796-808, 2018 | 142 | 2018 |
| Targeting bromodomain and extra-terminal (BET) family proteins in castration-resistant prostate cancer (CRPC) J Welti, A Sharp, W Yuan, D Dolling, D Nava Rodrigues, I Figueiredo, ... Clinical Cancer Research 24 (13), 3149-3162, 2018 | 137 | 2018 |
| The emerging role of speckle-type POZ protein (SPOP) in cancer development RS Mani Drug discovery today 19 (9), 1498-1502, 2014 | 116 | 2014 |
| The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma R Banerjee, RS Mani, N Russo, CS Scanlon, A Tsodikov, X Jing, Q Cao, ... Oncogene 30 (42), 4339-4349, 2011 | 114 | 2011 |
| Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss RS Mani, A Ganapathy, R Jalvi, CR Srikumari Srisailapathy, V Malhotra, ... European Journal of Human Genetics 17 (4), 502-509, 2009 | 96 | 2009 |
| Role of transcriptional corepressor CtBP1 in prostate cancer progression R Wang, IA Asangani, BVSK Chakravarthi, B Ateeq, RJ Lonigro, Q Cao, ... Neoplasia 14 (10), 905-IN8, 2012 | 89 | 2012 |
| Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer RS Mani, MA Amin, X Li, S Kalyana-Sundaram, BA Veeneman, L Wang, ... Cell reports 17 (10), 2620-2631, 2016 | 88 | 2016 |
| Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells S He, J Wang, K Kato, F Xie, S Varambally, S Mineishi, R Kuick, ... Blood, The Journal of the American Society of Hematology 119 (5), 1274-1282, 2012 | 77 | 2012 |
| Androgen receptor variants mediate DNA repair after prostate cancer irradiation Y Yin, R Li, K Xu, S Ding, J Li, GH Baek, SG Ramanand, S Ding, Z Liu, ... Cancer research 77 (18), 4745-4754, 2017 | 67 | 2017 |
| TMPRSS2–ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers RS Mani, MK Iyer, Q Cao, JC Brenner, L Wang, A Ghosh, X Cao, ... Cancer research 71 (16), 5387-5392, 2011 | 67 | 2011 |
| The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease S He, F Xie, Y Liu, Q Tong, K Mochizuki, PE Lapinski, RS Mani, P Reddy, ... Blood, The Journal of the American Society of Hematology 122 (25), 4119-4128, 2013 | 65 | 2013 |
